Evidence map›Paper›PMID 30682772›Full record

ReviewInternational journal of molecular sciences2019

The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer.

Rossella Cianci, Laura Franza, Giovanni Schinzari, Ernesto Rossi, Gianluca Ianiro, Giampaolo Tortora, Antonio Gasbarrini, Giovanni Gambassi, Giovanni Cammarota

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Observational
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. The Interplay betweenInternational journal of molecular sciences · 2023
    Review
  12. Gut microbiota and immunotherapy of renal cell carcinoma.Human vaccines & immunotherapeutics · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Gut Microbiota Host-Gene Interaction.International journal of molecular sciences · 2022
    Review
  19. Review
  20. The interplay betweenFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rossella CianciDepartment of Internal Medicine, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168 Roma, Italy. rossellacianci@gmail.com.ORCID 0000-0001-5378-8442
Laura FranzaDepartment of Internal Medicine, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168 Roma, Italy. laura.franza01@icatt.it.ORCID 0000-0001-8638-7565
Giovanni SchinzariDepartment of Medical Oncology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168 Roma, Italy, giovanni.schinzari@unicatt.it (G.S.). giovanni.schinzari@unicatt.it.
Ernesto RossiDepartment of Medical Oncology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168 Roma, Italy, giovanni.schinzari@unicatt.it (G.S.). ernestorossi.rm@gmail.com.
Gianluca IaniroDepartment of Gastroenterology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168 Roma, Italy. gianluca.ianiro@hotmail.it.
Giampaolo TortoraDepartment of Medical Oncology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168 Roma, Italy, giovanni.schinzari@unicatt.it (G.S.). giampaolo.tortora@policlinicogemelli.it.
Antonio GasbarriniDepartment of Gastroenterology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168 Roma, Italy. antonio.gasbarrini@unicatt.it.
Giovanni GambassiDepartment of Internal Medicine, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168 Roma, Italy. giovanni.gambassi@unicatt.it.
Giovanni CammarotaDepartment of Gastroenterology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli, 8, 00168 Roma, Italy. giovanni.cammarota@unicatt.it.
Università Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota is central to the pathogenesis of several inflammatory and autoimmune diseases. While multiple mechanisms are involved, the immune system clearly plays a special role. Indeed, the breakdown of the physiological balance in gut microbial composition leads to dysbiosis, which is then able to enhance inflammation and to influence gene expression. At the same time, there is an intense cross-talk between the microbiota and the immunological niche in the intestinal mucosa. These interactions may pave the way to the development, growth and spreading of cancer, especially in the gastro-intestinal system. Here, we review the changes in microbiota composition, how they relate to the immunological imbalance, influencing the onset of different types of cancer and the impact of these mechanisms on the efficacy of traditional and upcoming cancer treatments.

Indexed as

AnimalsGastrointestinal MicrobiomeGastrointestinal NeoplasmsHumansIntestinal Mucosacancerdysbiosisgut microbiotaimmune systemimmunological niche

Identifiers

PMID30682772
PMCPMC6387318
OpenAlexW2914267021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.